Wei, Wei https://orcid.org/0000-0001-8110-0705
Lyu, Xuchao https://orcid.org/0000-0003-1967-3902
Markhard, Andrew L.
Fu, Sipei
Mardjuki, Rachel E.
Cavanagh, Peter E. https://orcid.org/0000-0003-3146-664X
Zeng, Xianfeng
Rajniak, Jakub
Lu, Nannan
Xiao, Shuke https://orcid.org/0000-0003-2103-128X
Zhao, Meng https://orcid.org/0000-0002-5415-8335
Moya-Garzon, Maria Dolores
Truong, Steven D. https://orcid.org/0000-0001-9624-4461
Chou, Jonathan Chiu‐Chun
Wat, Lianna W. https://orcid.org/0000-0001-6998-0594
Chidambaranathan-Reghupaty, Saranya
Coassolo, Laetitia
Xu, Duo https://orcid.org/0000-0003-0483-8719
Shen, Fangfang
Huang, Wentao
Ramirez, Cuauhtemoc B.
Jang, Cholsoon https://orcid.org/0000-0001-6651-4213
Li, Lingyin https://orcid.org/0000-0003-4386-7926
Svensson, Katrin J. https://orcid.org/0000-0001-5376-5128
Fischbach, Michael A.
Long, Jonathan Z. https://orcid.org/0000-0003-2631-7463
Article History
Received: 27 October 2023
Accepted: 9 July 2024
First Online: 7 August 2024
Competing interests
: A provisional patent application has been filed by Stanford University on PTER–<i>N</i>-acetyltaurine for the treatment of cardiometabolic disease.